tirzepatide compound shortage FDA Announces End of Shortage: What This Means for Medspas and Compounders hormone GLP FDA ban on compounded tirzepatide:

Its table calls freezing below 0 degrees Celsius, or repeated freeze-thaw, a high risk with immediate degradation likely, and says such product should not be used and the pharmacy contacted for replacement

Lancet 390 , 21832193 (2017)

Check Out These Wellness Stories Next: The Best Wellness Trends of 2026, According to Professionals Why Everyone Is Talking About Cortisol Detoxing How to Reset Your Nervous System for Lower Cortisol and a Calmer, Clearer Mind Are You Taking Your Supplements the Right Way

Some clinical studies suggest that GLP-1 medications can slightly increase the resting heart rate or, conversely, lower blood pressure as weight loss occurs

Maintain at least 1 inch distance from previous injection sites